ORKA Q1 2018 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6,000

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-43.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$13M

Total Liabilities

$2M

Stockholders' Equity

$11M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,000	-$7,000	+14.3%
Operating Income	-$3M	-$4M	+36.7%
Net Income	-$3M	-$4M	+37.0%